Po-Hui Wang

542 total citations
30 papers, 386 citations indexed

About

Po-Hui Wang is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Po-Hui Wang has authored 30 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Po-Hui Wang's work include Reproductive System and Pregnancy (6 papers), Uterine Myomas and Treatments (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Po-Hui Wang is often cited by papers focused on Reproductive System and Pregnancy (6 papers), Uterine Myomas and Treatments (5 papers) and Endometrial and Cervical Cancer Treatments (4 papers). Po-Hui Wang collaborates with scholars based in Taiwan and United States. Po-Hui Wang's co-authors include Shun‐Fa Yang, Hsiu‐Ting Tsai, Chih‐Ping Han, Long-Yau Lin, Lai‐Fong Kok, Yeu-Sheng Tyan, Ya‐Wen Cheng, Ming-Yung Lee, Jiunn‐Liang Ko and Yu-Fan Liu and has published in prestigious journals such as PLoS ONE, Fertility and Sterility and Clinica Chimica Acta.

In The Last Decade

Po-Hui Wang

30 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Po-Hui Wang Taiwan	13	156	83	74	63	62	30	386
Aska Toda Japan	10	240 1.5×	124 1.5×	85 1.1×	189 3.0×	36 0.6×	21	470
Zhu Zhang China	13	129 0.8×	119 1.4×	88 1.2×	63 1.0×	26 0.4×	57	523
Annie-France Bringuier France	12	170 1.1×	51 0.6×	89 1.2×	42 0.7×	28 0.5×	15	390
Yuko Takano Japan	12	122 0.8×	65 0.8×	134 1.8×	51 0.8×	55 0.9×	34	405
Qing Cong China	14	208 1.3×	64 0.8×	65 0.9×	153 2.4×	40 0.6×	50	579
Cláudio Galleano Zettler Brazil	13	153 1.0×	62 0.7×	197 2.7×	100 1.6×	45 0.7×	43	597
Xiaoping Xia China	12	177 1.1×	41 0.5×	160 2.2×	170 2.7×	30 0.5×	36	451
M. A. Nikolaeva Russia	11	114 0.7×	150 1.8×	27 0.4×	39 0.6×	14 0.2×	38	430
Ola A. Harb Egypt	12	101 0.6×	22 0.3×	59 0.8×	71 1.1×	92 1.5×	61	462
Alexander Zukiwski United States	11	97 0.6×	55 0.7×	97 1.3×	22 0.3×	72 1.2×	26	335

Countries citing papers authored by Po-Hui Wang

Since Specialization

Citations

This map shows the geographic impact of Po-Hui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Po-Hui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Po-Hui Wang more than expected).

Fields of papers citing papers by Po-Hui Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Po-Hui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Po-Hui Wang. The network helps show where Po-Hui Wang may publish in the future.

Co-authorship network of co-authors of Po-Hui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Po-Hui Wang. A scholar is included among the top collaborators of Po-Hui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Po-Hui Wang. Po-Hui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Po-Hui, et al.. (2024). Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients. International Journal of Medical Sciences. 21(8). 1428–1437. 1 indexed citations

Ko, Jiunn‐Liang, Hsiu‐Ting Tsai, Ming‐Hsien Chien, et al.. (2014). The Expression of Ribonucleotide Reductase M2 in the Carcinogenesis of Uterine Cervix and Its Relationship with Clinicopathological Characteristics and Prognosis of Cancer Patients. PLoS ONE. 9(3). e91644–e91644. 19 indexed citations

Yu, Yung‐Luen, et al.. (2014). Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features. PLoS ONE. 9(4). e93635–e93635. 11 indexed citations

Liu, Yu-Fan, Shun‐Fa Yang, Ming‐Hsien Chien, et al.. (2014). Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms and Haplotypes with Uterine Cervical Cancer in Taiwanese Women. PLoS ONE. 9(9). e104038–e104038. 14 indexed citations

Wang, Po-Hui, et al.. (2014). Correlation of plasma osteopontin and neutrophil gelatinase-associated lipocalin levels with the severity and clinical outcome of pelvic inflammatory disease. Taiwanese Journal of Obstetrics and Gynecology. 53(2). 158–161. 5 indexed citations

Wu, Chih-Hsien, Jiunn‐Liang Ko, Yu-Wen Lin, et al.. (2013). Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix. Gynecologic Oncology. 132(2). 474–482. 13 indexed citations

Ko, Jiunn‐Liang, et al.. (2013). Increased concentrations of plasma growth arrest-specific 6 and its soluble tyrosine kinase receptor sAxl in Taiwanese women with pelvic inflammatory disease. Clinica Chimica Acta. 426. 85–90. 3 indexed citations

Wang, Po-Hui, et al.. (2012). Significantly increased concentration of soluble urokinase-type plasminogen activator receptor in the blood of patients with pelvic inflammatory disease. Clinica Chimica Acta. 415. 138–144. 6 indexed citations

Wang, Po-Hui, Jiunn‐Liang Ko, Shun‐Fa Yang, et al.. (2011). Significant Relation of Tissue Inhibitor of Matrix Metalloproteinase-2 and Its Combination With Matrix Metalloproteinase-2 to Survival of Patients With Cancer of Uterine Cervix. Reproductive Sciences. 18(8). 798–808. 3 indexed citations

10.

Tsai, Hsiu‐Ting, Pen-Hua Su, Tsung‐Hsien Lee, et al.. (2011). Significant elevation and correlation of plasma neutrophil gelatinase associated lipocalin and its complex with matrix metalloproteinase-9 in patients with pelvic inflammatory disease. Clinica Chimica Acta. 412(13-14). 1252–1256. 18 indexed citations

11.

Wang, Po-Hui, Hsiu‐Ting Tsai, Jiunn‐Liang Ko, et al.. (2010). Polymorphisms of Human Nonmetastatic Clone 23 Type 1 Gene and Neoplastic Lesions of Uterine Cervix. Reproductive Sciences. 17(10). 886–893. 10 indexed citations

12.

Wang, Po-Hui, Yu-Fan Liu, Hsiu‐Ting Tsai, et al.. (2010). Elevated Plasma Osteopontin Level is Associated With Pelvic Inflammatory Disease. Reproductive Sciences. 17(11). 1052–1058. 11 indexed citations

13.

Wang, Po-Hui, Hsiu‐Ting Tsai, Jiunn‐Liang Ko, et al.. (2010). Significant association of genetic polymorphism of human nonmetastatic clone 23 type 1 gene with an increased risk of endometrial cancer. Gynecologic Oncology. 119(1). 70–75. 11 indexed citations

14.

Tsai, Hsiu‐Ting, Yi‐Hsien Hsieh, Hui‐Ling Chiou, et al.. (2009). Elevated Plasma Stromal Cell-derived Factor 1 Protein and its Gene Polymorphism in Patients With Pelvic Inflammatory Disease. Reproductive Sciences. 16(6). 610–617. 7 indexed citations

15.

Kok, Lai‐Fong, Ming-Yung Lee, Yeu-Sheng Tyan, et al.. (2009). Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study. Archives of Gynecology and Obstetrics. 281(2). 293–300. 25 indexed citations

16.

Han, Chih‐Ping, Lai‐Fong Kok, Po-Hui Wang, et al.. (2009). Scoring of p16INK4a immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray study. Modern Pathology. 22(6). 797–806. 55 indexed citations

17.

Han, Chih‐Ping, Ming-Yung Lee, Lai‐Fong Kok, et al.. (2009). A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Archives of Gynecology and Obstetrics. 281(5). 845–850. 4 indexed citations

18.

Kok, Lai‐Fong, Ming-Yung Lee, Po-Hui Wang, et al.. (2009). Ancillary p16INK4a adds no meaningful value to the performance of ER/PR/Vim/CEA panel in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study. Archives of Gynecology and Obstetrics. 280(3). 405–413. 13 indexed citations

19.

Tsai, Hsiu‐Ting, et al.. (2008). Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease. Fertility and Sterility. 91(2). 549–555. 14 indexed citations

20.

Wang, Po-Hui, Shun‐Fa Yang, Long-Yau Lin, et al.. (2008). Significant elevation of a Th2 cytokine, interleukin-10, in pelvic inflammatory disease. Clinical Chemistry and Laboratory Medicine (CCLM). 46(11). 1609–16. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact